Delivery Order SPE2DB20D1100-SPE2DB25FE0UF
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 ml vials with a ceiling value of $2,101.84. This non-competitive, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,175.30 to AmerisourceBergen Drug Corp for the supply of Gadavist 1 mmol/ml bulk vials (30ml). This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $1,136.62 to AmerisourceBergen Drug Corp for Gadavist 1 mmol/mL bulk vial (30 mL) on June 17, 2025, with completion scheduled for June 18, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier of...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.64 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,612.16 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gadavist 7.5 mmol/7.5 ml vials. The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a pediatric or diagnostic imaging pharmaceutical product supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials with a ceiling value of $1,501.90. This non-competitive, firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gadavist is a contrast agent used in medical imaging procedures, reflecting the company's role as a critical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $9,097.83 for Gadavist 10 mmol/10 ml vials from the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, with a completion date of September 22, 2025. This firm fixed-price delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This is a $2,366.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product Gadavist, a 10 milliliter vial containing 10 millimoles per milliliter. The delivery order has a completion date of June 11, 2025 and is not set aside for any small business categories. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.90 to AmerisourceBergen Drug Corp for Gadavist 1 mmol/ml bulk vials (30 ml) on May 14, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gadavist is a gadolinium-based contrast agent used in magnetic resonance imaging procedures...
- The Defense Logistics Agency awarded a $2,809.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 mL vials, a gadolinium-based contrast agent used in magnetic resonance imaging procedures. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, was competitively awarded without set-aside provisions and is scheduled for completion by September 3, 2025. AmerisourceBergen,...